Keyphrases
Postpartum Hemorrhage
100%
Maternal Plasma
100%
Plasma Cytokines
100%
Uterine Atony
100%
Pregnant Women
33%
Plasma Concentration
33%
Interleukin-1β
22%
Interleukin-12 (IL-12)
22%
Interleukin-6
22%
Leave-one-out
22%
Monocyte Chemoattractant protein-1 (MCP-1)
22%
Interleukin
22%
Interleukin-16 (IL-16)
22%
Therapeutic Target
11%
Performance Prediction
11%
Clinical Information
11%
Area under the ROC Curve
11%
Gestational Age at Delivery
11%
Mode of Delivery
11%
Preeclampsia
11%
Maternal Age
11%
Demographic Information
11%
False Discovery Rate
11%
Retrospective Case-Control Design
11%
Linear Mixed Model
11%
Plasma Samples
11%
Multiple Testing
11%
Random Forest
11%
Random Forest Regression
11%
Multi-protein
11%
Multi-omic Models
11%
Clinical Chorioamnionitis
11%
Labor Status
11%
Combined Value
11%
Medicine and Dentistry
Cytokine
100%
Lochia
100%
Maternal Plasma
100%
Uterine Atony
100%
Cross-Validation
33%
Interleukin 1
22%
Interleukin 12
22%
Interleukin 6
22%
Monocyte Chemotactic Protein 1
22%
Interleukin 16
22%
Biological Marker
11%
Proteomics
11%
Chorioamnionitis
11%
Pre-Eclampsia
11%
Maternal Age
11%
Case-Control Study
11%
Gestational Age
11%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Blood Plasma
100%
Blood Level
50%
Interleukin-1
33%
Synapsin I
33%
Interleukin 6
33%
Interleukin
33%
Interleukin 12
33%
Random Forest
33%
Interleukin 16
33%
Proteomics
16%
Case-Control Study
16%
Maternal Age
16%
Immunology and Microbiology
Cytokine
100%
Maternal Plasma
100%
Blood Level
50%
Interleukin 1
33%
Interleukin 6
33%
Monocyte Chemotactic Protein 1
33%
Random Forest
33%
Interleukin
33%
Interleukin 16
33%
Interleukin 12
33%
Maternal Age
16%
Chorioamnionitis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Postpartum Hemorrhage
100%
Uterine Atony
100%
Cross-Validation
33%
Interleukin 1
22%
Interleukin 6
22%
Monocyte Chemotactic Protein 1
22%
Interleukin 12
22%
Interleukin 16
22%
Biological Marker
11%
Preeclampsia
11%
Case-Control Study
11%
Chorioamnionitis
11%